1. Improve utilization & adherence to GL recommended therapies in CV prevention.
2. Improve identification and treatment of FH.
3. Improve use of partnerships and registries for care.
12/07/2018 - 12:00pm to 1:00pm CST
Chicago, IL 60637
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Laurence S. Sperling, MD, FACC, FAHA, FACP, FASPC